BioPharmSignal logoBioPharmSignal

Company Profile

Ocean Biomedical Stock Price, News & Analysis

Ticker:
OCEA
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

0.00 USD (0.00%)

Close

Last updated: August 5, 2026

—

Market cap

Why the stock is moving

Current closing-price context is not available for OCEA.

Company overview

Business overview

Ocean Biomedical is a biotech company that has pursued multiple discovery and development directions, often with a focus on novel cancer and inflammatory disease concepts. Its identity has been shaped by platform ambition and capital markets evolution.

Geographic Base and Sector Classification

Ocean Biomedical is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.

Business Model Characteristics

The company depends on strategic focus, scientific validation, and capital efficiency. Investors usually watch corporate restructuring, pipeline prioritization, and funding.

Position Within the Biotechnology Landscape

Ocean Biomedical occupies a speculative small-cap biotech niche. The stock is driven more by strategy and financing than by mature commercial execution.

Future catalysts

Ocean Biomedical is largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is focused on residual value.

Recent news

  1. 01

    Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value

    Source: Ocean Biomedical

  2. 02

    Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China

    Source: Ocean Biomedical

  3. 03

    Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development

    Source: Ocean Biomedical

  4. 04

    Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

    Source: Ocean Biomedical

  5. 05

    Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

    Source: Ocean Biomedical

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

IGC

IGC Pharma, Inc.

NAVB

Navidea

TLSA

Tiziana Life Sciences

INM

InMed

IBIO

IBIO

GRI

GRI Bio

SLRN

ACELYRIN, INC.

GOVX

GeoVax Labs

Frequently Asked Questions

What is the current stock price of Ocean Biomedical (OCEA)?

Ocean Biomedical (OCEA) most recently closed at 0.00 USD, a 0.00% move versus the previous session.

What does Ocean Biomedical do?

Ocean Biomedical is a biotech company that has pursued multiple discovery and development directions, often with a focus on novel cancer and inflammatory disease concepts. Its identity has been shaped by platform ambition and capital markets evolution.

On which exchange is OCEA stock listed?

Ocean Biomedical (OCEA) is associated with NASDAQ, United States, Biopharma.

What is Ocean?

Ocean Biomedical is largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.

Which conditions is Ocean Biomedical targeting with Ocean?

Ocean Biomedical is associated with cancer therapeutics based on its company overview and current catalyst commentary.

How does Ocean Biomedical describe recent progress with Ocean?

Ocean Biomedical is largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.

What is Biomedical?

Ocean Biomedical is a biotech company that has pursued multiple discovery and development directions, often with a focus on novel cancer and inflammatory disease concepts.

What should investors watch for with Biomedical?

Ocean Biomedical is largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.